SCHEMBL7125325

SCHEMBL7125325

CCS(=O)(=O)N(c1ccc(-c2ccc(NC(=O)c3cc([N+](=O)[O-])ccc3Cl)cc2)cc1)S(=O)(=O)CC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 6/20 0.58
MAPT P10636 5/20 0.58
KMT2A Q03164 4/20 0.58
SMN1; SMN2 Q16637 4/20 0.58
RORC P51449 4/20 0.58
MEN1 O00255 3/20 0.58
MAPK1 P28482 3/20 0.58
CYP3A4 P08684 3/20 0.58
LMNA P02545 2/20 0.58
TP53 P04637 1/20 0.58
CYP1A2 P05177 1/20 0.58
CYP2D6 P10635 1/20 0.58
CYP2C9 P11712 1/20 0.58
PKM P14618 1/20 0.58
TSHR P16473 1/20 0.58
NFKB1 P19838 1/20 0.58
CYP2C19 P33261 1/20 0.58
THPO P40225 1/20 0.58
MTOR P42345 1/20 0.58
PMP22 Q01453 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7130676 0.90 MAPT (0.61) PPARGMAPTKMT2ASMN1; SMN2RORC
SCHEMBL7118603 0.88 PPARG (0.61) PPARGMAPTKMT2ASMN1; SMN2RORC
SCHEMBL7130312 0.87 PPARG (0.63) PPARGMAPTKMT2ASMN1; SMN2RORC
SCHEMBL7130570 0.86 MAPT (0.61) PPARGMAPTKMT2ASMN1; SMN2RORC
SCHEMBL7129476 0.86 PPARG (0.58) PPARGMAPTKMT2ASMN1; SMN2RORC
SCHEMBL7130566 0.86 MAPT (0.59) PPARGMAPTKMT2ASMN1; SMN2RORC
SCHEMBL7127017 0.85 MAPT (0.61) PPARGMAPTKMT2ASMN1; SMN2RORC
SCHEMBL7120601 0.85 MAPT (0.77) PPARGMAPTKMT2ASMN1; SMN2RORC
SCHEMBL7128744 0.85 PPARG (0.57) PPARGMAPTKMT2ASMN1; SMN2RORC
SCHEMBL7121705 0.84 RORC (0.80) PPARGMAPTKMT2ASMN1; SMN2RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US claimed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD PPARG 1/4885MAPT 4391/4885KMT2A 3291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.